The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologic-Device Combination Products Market Research Report 2025
Synopsis
A biologic-device combination product is a marriage between two partners with "cultural differences". There are clear differences in the development, review, and commercialization processes of the biologic and the device. Some biological products are associated with a device or drug to form a therapeutic product.
The global Biologic-Device Combination Products market was valued at US$ 6720 million in 2023 and is anticipated to reach US$ 12210 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Biologic-Device Combination Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic-Device Combination Products.
Report Scope
The Biologic-Device Combination Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologic-Device Combination Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic-Device Combination Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Baxter BioPharma Solution
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
Roselabs Group
West Pharma
Segment by Type
Prefilled Syringes
Autoinjectors
Others
Segment by Application
Vaccines
Antithrombotic Drugs
Bioengineering Drugs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic-Device Combination Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A biologic-device combination product is a marriage between two partners with "cultural differences". There are clear differences in the development, review, and commercialization processes of the biologic and the device. Some biological products are associated with a device or drug to form a therapeutic product.
The global Biologic-Device Combination Products market was valued at US$ 6720 million in 2023 and is anticipated to reach US$ 12210 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Biologic-Device Combination Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic-Device Combination Products.
Report Scope
The Biologic-Device Combination Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologic-Device Combination Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic-Device Combination Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Baxter BioPharma Solution
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
Roselabs Group
West Pharma
Segment by Type
Prefilled Syringes
Autoinjectors
Others
Segment by Application
Vaccines
Antithrombotic Drugs
Bioengineering Drugs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic-Device Combination Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic-Device Combination Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prefilled Syringes
1.2.3 Autoinjectors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biologic-Device Combination Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vaccines
1.3.3 Antithrombotic Drugs
1.3.4 Bioengineering Drugs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic-Device Combination Products Market Perspective (2019-2030)
2.2 Biologic-Device Combination Products Growth Trends by Region
2.2.1 Global Biologic-Device Combination Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologic-Device Combination Products Historic Market Size by Region (2019-2024)
2.2.3 Biologic-Device Combination Products Forecasted Market Size by Region (2025-2030)
2.3 Biologic-Device Combination Products Market Dynamics
2.3.1 Biologic-Device Combination Products Industry Trends
2.3.2 Biologic-Device Combination Products Market Drivers
2.3.3 Biologic-Device Combination Products Market Challenges
2.3.4 Biologic-Device Combination Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic-Device Combination Products Players by Revenue
3.1.1 Global Top Biologic-Device Combination Products Players by Revenue (2019-2024)
3.1.2 Global Biologic-Device Combination Products Revenue Market Share by Players (2019-2024)
3.2 Global Biologic-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologic-Device Combination Products Revenue
3.4 Global Biologic-Device Combination Products Market Concentration Ratio
3.4.1 Global Biologic-Device Combination Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic-Device Combination Products Revenue in 2023
3.5 Biologic-Device Combination Products Key Players Head office and Area Served
3.6 Key Players Biologic-Device Combination Products Product Solution and Service
3.7 Date of Enter into Biologic-Device Combination Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic-Device Combination Products Breakdown Data by Type
4.1 Global Biologic-Device Combination Products Historic Market Size by Type (2019-2024)
4.2 Global Biologic-Device Combination Products Forecasted Market Size by Type (2025-2030)
5 Biologic-Device Combination Products Breakdown Data by Application
5.1 Global Biologic-Device Combination Products Historic Market Size by Application (2019-2024)
5.2 Global Biologic-Device Combination Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologic-Device Combination Products Market Size (2019-2030)
6.2 North America Biologic-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologic-Device Combination Products Market Size by Country (2019-2024)
6.4 North America Biologic-Device Combination Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologic-Device Combination Products Market Size (2019-2030)
7.2 Europe Biologic-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologic-Device Combination Products Market Size by Country (2019-2024)
7.4 Europe Biologic-Device Combination Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologic-Device Combination Products Market Size (2019-2030)
8.2 Asia-Pacific Biologic-Device Combination Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologic-Device Combination Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Biologic-Device Combination Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologic-Device Combination Products Market Size (2019-2030)
9.2 Latin America Biologic-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologic-Device Combination Products Market Size by Country (2019-2024)
9.4 Latin America Biologic-Device Combination Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic-Device Combination Products Market Size (2019-2030)
10.2 Middle East & Africa Biologic-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologic-Device Combination Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Biologic-Device Combination Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Biologic-Device Combination Products Introduction
11.1.4 BD Revenue in Biologic-Device Combination Products Business (2019-2024)
11.1.5 BD Recent Development
11.2 Gerresheimer
11.2.1 Gerresheimer Company Detail
11.2.2 Gerresheimer Business Overview
11.2.3 Gerresheimer Biologic-Device Combination Products Introduction
11.2.4 Gerresheimer Revenue in Biologic-Device Combination Products Business (2019-2024)
11.2.5 Gerresheimer Recent Development
11.3 Nipro Corporation
11.3.1 Nipro Corporation Company Detail
11.3.2 Nipro Corporation Business Overview
11.3.3 Nipro Corporation Biologic-Device Combination Products Introduction
11.3.4 Nipro Corporation Revenue in Biologic-Device Combination Products Business (2019-2024)
11.3.5 Nipro Corporation Recent Development
11.4 Schott
11.4.1 Schott Company Detail
11.4.2 Schott Business Overview
11.4.3 Schott Biologic-Device Combination Products Introduction
11.4.4 Schott Revenue in Biologic-Device Combination Products Business (2019-2024)
11.4.5 Schott Recent Development
11.5 Stevanato
11.5.1 Stevanato Company Detail
11.5.2 Stevanato Business Overview
11.5.3 Stevanato Biologic-Device Combination Products Introduction
11.5.4 Stevanato Revenue in Biologic-Device Combination Products Business (2019-2024)
11.5.5 Stevanato Recent Development
11.6 Baxter BioPharma Solution
11.6.1 Baxter BioPharma Solution Company Detail
11.6.2 Baxter BioPharma Solution Business Overview
11.6.3 Baxter BioPharma Solution Biologic-Device Combination Products Introduction
11.6.4 Baxter BioPharma Solution Revenue in Biologic-Device Combination Products Business (2019-2024)
11.6.5 Baxter BioPharma Solution Recent Development
11.7 Rovi CM
11.7.1 Rovi CM Company Detail
11.7.2 Rovi CM Business Overview
11.7.3 Rovi CM Biologic-Device Combination Products Introduction
11.7.4 Rovi CM Revenue in Biologic-Device Combination Products Business (2019-2024)
11.7.5 Rovi CM Recent Development
11.8 Terumo
11.8.1 Terumo Company Detail
11.8.2 Terumo Business Overview
11.8.3 Terumo Biologic-Device Combination Products Introduction
11.8.4 Terumo Revenue in Biologic-Device Combination Products Business (2019-2024)
11.8.5 Terumo Recent Development
11.9 Vetter
11.9.1 Vetter Company Detail
11.9.2 Vetter Business Overview
11.9.3 Vetter Biologic-Device Combination Products Introduction
11.9.4 Vetter Revenue in Biologic-Device Combination Products Business (2019-2024)
11.9.5 Vetter Recent Development
11.10 Catalent
11.10.1 Catalent Company Detail
11.10.2 Catalent Business Overview
11.10.3 Catalent Biologic-Device Combination Products Introduction
11.10.4 Catalent Revenue in Biologic-Device Combination Products Business (2019-2024)
11.10.5 Catalent Recent Development
11.11 Taisei Kako
11.11.1 Taisei Kako Company Detail
11.11.2 Taisei Kako Business Overview
11.11.3 Taisei Kako Biologic-Device Combination Products Introduction
11.11.4 Taisei Kako Revenue in Biologic-Device Combination Products Business (2019-2024)
11.11.5 Taisei Kako Recent Development
11.12 Roselabs Group
11.12.1 Roselabs Group Company Detail
11.12.2 Roselabs Group Business Overview
11.12.3 Roselabs Group Biologic-Device Combination Products Introduction
11.12.4 Roselabs Group Revenue in Biologic-Device Combination Products Business (2019-2024)
11.12.5 Roselabs Group Recent Development
11.13 West Pharma
11.13.1 West Pharma Company Detail
11.13.2 West Pharma Business Overview
11.13.3 West Pharma Biologic-Device Combination Products Introduction
11.13.4 West Pharma Revenue in Biologic-Device Combination Products Business (2019-2024)
11.13.5 West Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biologic-Device Combination Products Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Prefilled Syringes
Table 3. Key Players of Autoinjectors
Table 4. Key Players of Others
Table 5. Global Biologic-Device Combination Products Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Biologic-Device Combination Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Biologic-Device Combination Products Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Biologic-Device Combination Products Market Share by Region (2019-2024)
Table 9. Global Biologic-Device Combination Products Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Biologic-Device Combination Products Market Share by Region (2025-2030)
Table 11. Biologic-Device Combination Products Market Trends
Table 12. Biologic-Device Combination Products Market Drivers
Table 13. Biologic-Device Combination Products Market Challenges
Table 14. Biologic-Device Combination Products Market Restraints
Table 15. Global Biologic-Device Combination Products Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Biologic-Device Combination Products Market Share by Players (2019-2024)
Table 17. Global Top Biologic-Device Combination Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic-Device Combination Products as of 2023)
Table 18. Ranking of Global Top Biologic-Device Combination Products Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Biologic-Device Combination Products Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biologic-Device Combination Products Product Solution and Service
Table 22. Date of Enter into Biologic-Device Combination Products Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biologic-Device Combination Products Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Biologic-Device Combination Products Revenue Market Share by Type (2019-2024)
Table 26. Global Biologic-Device Combination Products Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Biologic-Device Combination Products Revenue Market Share by Type (2025-2030)
Table 28. Global Biologic-Device Combination Products Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Biologic-Device Combination Products Revenue Market Share by Application (2019-2024)
Table 30. Global Biologic-Device Combination Products Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Biologic-Device Combination Products Revenue Market Share by Application (2025-2030)
Table 32. North America Biologic-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Biologic-Device Combination Products Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Biologic-Device Combination Products Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Biologic-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Biologic-Device Combination Products Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Biologic-Device Combination Products Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Biologic-Device Combination Products Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Biologic-Device Combination Products Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Biologic-Device Combination Products Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Biologic-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Biologic-Device Combination Products Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Biologic-Device Combination Products Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Biologic-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Biologic-Device Combination Products Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Biologic-Device Combination Products Market Size by Country (2025-2030) & (US$ Million)
Table 47. BD Company Detail
Table 48. BD Business Overview
Table 49. BD Biologic-Device Combination Products Product
Table 50. BD Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 51. BD Recent Development
Table 52. Gerresheimer Company Detail
Table 53. Gerresheimer Business Overview
Table 54. Gerresheimer Biologic-Device Combination Products Product
Table 55. Gerresheimer Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 56. Gerresheimer Recent Development
Table 57. Nipro Corporation Company Detail
Table 58. Nipro Corporation Business Overview
Table 59. Nipro Corporation Biologic-Device Combination Products Product
Table 60. Nipro Corporation Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 61. Nipro Corporation Recent Development
Table 62. Schott Company Detail
Table 63. Schott Business Overview
Table 64. Schott Biologic-Device Combination Products Product
Table 65. Schott Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 66. Schott Recent Development
Table 67. Stevanato Company Detail
Table 68. Stevanato Business Overview
Table 69. Stevanato Biologic-Device Combination Products Product
Table 70. Stevanato Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 71. Stevanato Recent Development
Table 72. Baxter BioPharma Solution Company Detail
Table 73. Baxter BioPharma Solution Business Overview
Table 74. Baxter BioPharma Solution Biologic-Device Combination Products Product
Table 75. Baxter BioPharma Solution Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 76. Baxter BioPharma Solution Recent Development
Table 77. Rovi CM Company Detail
Table 78. Rovi CM Business Overview
Table 79. Rovi CM Biologic-Device Combination Products Product
Table 80. Rovi CM Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 81. Rovi CM Recent Development
Table 82. Terumo Company Detail
Table 83. Terumo Business Overview
Table 84. Terumo Biologic-Device Combination Products Product
Table 85. Terumo Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 86. Terumo Recent Development
Table 87. Vetter Company Detail
Table 88. Vetter Business Overview
Table 89. Vetter Biologic-Device Combination Products Product
Table 90. Vetter Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 91. Vetter Recent Development
Table 92. Catalent Company Detail
Table 93. Catalent Business Overview
Table 94. Catalent Biologic-Device Combination Products Product
Table 95. Catalent Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 96. Catalent Recent Development
Table 97. Taisei Kako Company Detail
Table 98. Taisei Kako Business Overview
Table 99. Taisei Kako Biologic-Device Combination Products Product
Table 100. Taisei Kako Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 101. Taisei Kako Recent Development
Table 102. Roselabs Group Company Detail
Table 103. Roselabs Group Business Overview
Table 104. Roselabs Group Biologic-Device Combination Products Product
Table 105. Roselabs Group Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 106. Roselabs Group Recent Development
Table 107. West Pharma Company Detail
Table 108. West Pharma Business Overview
Table 109. West Pharma Biologic-Device Combination Products Product
Table 110. West Pharma Revenue in Biologic-Device Combination Products Business (2019-2024) & (US$ Million)
Table 111. West Pharma Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic-Device Combination Products Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Biologic-Device Combination Products Market Share by Type: 2023 VS 2030
Figure 3. Prefilled Syringes Features
Figure 4. Autoinjectors Features
Figure 5. Others Features
Figure 6. Global Biologic-Device Combination Products Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Biologic-Device Combination Products Market Share by Application: 2023 VS 2030
Figure 8. Vaccines Case Studies
Figure 9. Antithrombotic Drugs Case Studies
Figure 10. Bioengineering Drugs Case Studies
Figure 11. Others Case Studies
Figure 12. Biologic-Device Combination Products Report Years Considered
Figure 13. Global Biologic-Device Combination Products Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Biologic-Device Combination Products Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Biologic-Device Combination Products Market Share by Region: 2023 VS 2030
Figure 16. Global Biologic-Device Combination Products Market Share by Players in 2023
Figure 17. Global Top Biologic-Device Combination Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic-Device Combination Products as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Biologic-Device Combination Products Revenue in 2023
Figure 19. North America Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Biologic-Device Combination Products Market Share by Country (2019-2030)
Figure 21. United States Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Biologic-Device Combination Products Market Share by Country (2019-2030)
Figure 25. Germany Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Biologic-Device Combination Products Market Share by Region (2019-2030)
Figure 33. China Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Biologic-Device Combination Products Market Share by Country (2019-2030)
Figure 41. Mexico Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Biologic-Device Combination Products Market Share by Country (2019-2030)
Figure 45. Turkey Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Biologic-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. BD Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 48. Gerresheimer Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 49. Nipro Corporation Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 50. Schott Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 51. Stevanato Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 52. Baxter BioPharma Solution Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 53. Rovi CM Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 54. Terumo Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 55. Vetter Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 56. Catalent Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 57. Taisei Kako Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 58. Roselabs Group Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 59. West Pharma Revenue Growth Rate in Biologic-Device Combination Products Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
